Dr. Rustagi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4150 Clement St
San Francisco, CA 94121Phone+1 415-221-4810
Summary
- Dr. Arjun Rustagi is an Assistant Professor in the Department of Medicine, Division of Infectious Diseases at the San Francisco VA Health Care System and the University of California, San Francisco. He received his MD and PhD from the University of Washington and completed residency and fellowship at Stanford University. He is experienced in infectious diseases, global health, and internal medicine.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2018 - 2021- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2015 - 2018
University of Washington School of MedicineClass of 2015
University of WashingtonPhD, Pathobiology, 2009 - 2013
Certifications & Licensure
CA State Medical License 2016 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- 2 citationsVaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.Timothy D Carroll, Talia Wong, Mary Kate Morris, Clara Di Germanio, Zhong-Min Ma
The Journal of Infectious Diseases. 2024-06-14 - 8 citationsInterstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung.Timothy Ting-Hsuan Wu, Kyle J Travaglini, Arjun Rustagi, Duo Xu, Yue Zhang
The Journal of Experimental Medicine. 2024-06-03 - 6 citationsAn orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.Michael Westberg, Yichi Su, Xinzhi Zou, Pinghan Huang, Arjun Rustagi
Science Translational Medicine. 2024-03-13
Press Mentions
Summaries of Health Policy Coverage from Major News OrganizationsAugust 16th, 2021- First Edition: Aug. 16, 2021August 16th, 2021
- Scientists Say a 'Doomsday' Variant After Delta Isn't Likely. But Here's What's PossibleAugust 14th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
